In lung and renal cell carcinoma models, intratumoral injection of CXCL9 or CXCL10 proteins, respectively, reduced neovascularization and delayed tumor growth by inducing tumor‐infiltrating CXCR3+ monocytes.317, 318. The gene discussed is CXCR3; the disease is neoplasm.